Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019 USD ($)
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flow attributable to operating leases	$ (9,978)
Operating cash flow attributable to finance leases	(51)
Financing cash flow attributable to finance leases	(274)
Supplemental noncash information:
Right-of-use assets obtained in exchange for operating lease liabilities	53,683	[1]
Right-of-use assets obtained in exchange for finance lease liabilities	$ 1,978	[2]

[1] No new operating leases were entered into during the year ended December 31, 2019.  Amount shown is due to the adoption of ASC 842 and one lease modification that resulted in a noncash remeasurement of the related right-of-use asset and operating lease liability. Amount shown reflects balance as of January 1, 2019 for the Healthcare segment (adjusted for lease modification) and as of March 8, 2019 for the Nutrition segment (i.e., the date of our acquisition of Nutrisystem)

[2] Amount shown is due to the adoption of ASC 842 and one new finance lease for $1.8 million entered into during the year ended December 31, 2019. In addition to such lease, amount shown reflects balance as of January 1, 2019 for the Healthcare segment. The Nutrition segment does not maintain any finance leases.